<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53614">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01867931</url>
  </required_header>
  <id_info>
    <org_study_id>NL39721.068.12</org_study_id>
    <nct_id>NCT01867931</nct_id>
  </id_info>
  <brief_title>Epithelial Damage in GERD</brief_title>
  <official_title>Characterisation of Esophageal Epithelial Damage in Patients With Non-erosive Reflux Disease (NERD) and Erosive Esophagitis (EE): Role of Epithelial Permeability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <authority>Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to characterize and compare epithelial damage in patients with
      erosive esophagitis and non-erosive reflux disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Epithelial integrity in tissue biopsies</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Immunohistochemical markers in tissue biopsies</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histological changes in tissue biopsies</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Gastro-esophageal Reflux Disease</condition>
  <arm_group>
    <arm_group_label>Erosive Esophagitis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-erosive Reflux Disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Heatlhy volunteers</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with EE and patients with NERD referred to the GI-outpatient clinic of the
        University Hospital Maastricht with an indication for diagnostic gastroscopy, as well
        healthy volunteers will be asked to participate in the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Typical GERD-symptoms lasting for more than 6 months (recurrent episodes of heartburn
             or acid regurgitation)

          -  abnormal pH-parameters (pathological acid exposure and/or symptom association)

        Exclusion Criteria:

          -  Age &lt;18 years

          -  Previous esophageal or gastric surgery

          -  Severe esophageal motility disorder on manometry

          -  Histological evidence of Barrett's mucosa

          -  Severe co-morbidities (including cardiopulmonary disease, portal   hypertension,
             collagen diseases, morbid obesity, coagulation disorders and co-morbidity hindering a
             gastroscopic procedure)

          -  Use of anticoagulant or immunosuppressive drugs

          -  Inability to stop medication that can influence the test results, like PPI, for at
             least 10 days before tests

          -  Excessive alcohol consumption (&gt;20 units per week)

          -  Patients unable to give informed consent.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J.M. Conchillo, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>N.F. Rinsma, MD</last_name>
    <phone>+31433875021</phone>
    <email>n.rinsma@maastrichtuniversity.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>J.M. Conchillo, MD PhD</last_name>
    <email>j.conchillo@mumc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <zip>6229 HX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>N.F. Rinsma, MD</last_name>
      <phone>+3143-3875021</phone>
      <email>n.rinsma@maastrichtuniversity.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Jovov B, Que J, Tobey NA, Djukic Z, Hogan BL, Orlando RC. Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease. Am J Gastroenterol. 2011 Jun;106(6):1039-47. doi: 10.1038/ajg.2011.102. Epub 2011 Mar 29.</citation>
    <PMID>21448147</PMID>
  </reference>
  <reference>
    <citation>Barlow WJ, Orlando RC. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology. 2005 Mar;128(3):771-8. Review.</citation>
    <PMID>15765412</PMID>
  </reference>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 5, 2014</lastchanged_date>
  <firstreceived_date>April 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
